Molecular and cellular targets

Molecular Carcinogenesis

Volumn 45, Issue 6, 2006, Pages 422-430

  Bode, Ann M ^a   Dong, Zigang ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Activator protein 1; Apoptosis; Caffeine; Catechins; EGCG; Nuclear factor kappa B; Theaflavins; Vimentin

Indexed keywords

BLACK TEA EXTRACT; CAFFEINE; CASPASE 3; CATECHIN; EPICATECHIN; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; POLYPHENOL DERIVATIVE; THEAFLAVIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TUMOR PROMOTER; VIMENTIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER; CANCER GENETICS; CANCER PREVENTION; CARCINOGENESIS; CELL CYCLE ARREST; CELL TRANSFORMATION; CHEMICAL STRUCTURE; CHEMOPROPHYLAXIS; CONFERENCE PAPER; DIETARY INTAKE; DRUG POTENCY; ENZYME ACTIVITY; GENETIC SUSCEPTIBILITY; HUMAN; NONHUMAN; ONCOGENE; OXIDATION; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; TEA; TRANSCRIPTION REGULATION;

BIFLAVONOIDS; CATECHIN; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; NEOPLASMS;

EID: 33745001652     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20222     Document Type: Conference Paper

References (94)

1. Bode AM, Dong Z. Apoptosis induction by arsenic: Mechanisms of actions and possible clinical applications for treating therapy-resistant cancers. Drug Resist Updates 2000;3:21-29.
2. Bode AM, Dong Z. Signal transduction pathways: Targets for chemoprevention of skin cancer. Lancet Oncol 2000;1:181-188.
3. Bode AM, Dong Z. The paradox of arsenic: Molecular mechanisms of cell transformation and chemotherapeutic effects. Crit Rev Oncol Hematol 2002;42:5-24.
4. Bode AM, Dong Z. Signal transduction pathways: Targets for green and black tea polyphenols. J Biochem Mol Biol 2003;36:66-77.
5. Bode AM, Dong Z. Mitogen-activated protein kinase activation in uv-induced signal transduction. Sci STKE 2003;2003:RE2.
6. Bode AM, Dong Z. Targeting signal transduction pathways by chemopreventive agents. Mutat Res 2004;555:33-51.
7. Bode AM, Dong Z. Post-translational modification of p53 in tumorigenesis. Nature Rev Cancer 2004;4:793-805.
8. Bode AM, Dong Z. Cancer prevention by food factors through targeting signal transduction pathways. Nutrition 2004;20:89-94.
9. Bode AM, Dong Z. Signal transduction pathways in cancer development and as targets for cancer prevention. Prog Nucleic Acid Res Mol Biol 2005;79:237-297.
10. Bode AM, Dong Z. Inducible covalent posttranslational modification of histone h3. Sci STKE 2005;2005:re4.
11. Davis RJ. Mapks: New jnk expands the group. Trends Biochem Sci 1994;19:470-473.
12. Angel P, Hattori K, Smeal T, Karin M. The jun proto-oncogene is positively autoregulated by its product, jun/ap-1. Cell 1988;55:875-885.
13. Kallunki T, Su B, Tsigelny I, et al. Jnk2 contains a specificity- determining region responsible for efficient c-jun binding and phosphorylation. Genes Dev 1994;8:2996-3007.
14. Sanchez I, Hughes RT, Mayer BJ, et al. Role of sapk/erk kinase-1 in the stress-activated pathway regulating transcription factor c-jun. Nature 1994;372:794-798.
15. Eferl R, Wagner EF. Ap-1: A double-edged sword in tumorigenesis. Nat Rev Cancer 2003;3:859-868.
16. Angel P, Karin M. The role of jun, fos and the ap-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1991;1072:129-157.
17. Barthelman M, Chen W, Gensler HL, Huang C, Dong Z, Bowden GT. Inhibitory effects of perillyl alcohol on UVB-induced murine skin cancer and ap-1 transactivation. Cancer Res 1998;58:711-716.
18. Dong Z, Watts SG, Sun Y, Colburn NH. Progressive elevation of ap-1 activity during preneoplastic-to neoplastic progression as modeled in mouse jb6 cell variants. Int J Oncol 1995;7:359-364.
19. Dong Z, Birrer MJ, Watts RG, Matrisian LM, Colburn NH. Blocking of tumor promoter-induced ap-1 activity inhibits induced transformation in jb6 mouse epidermal cells. Proc Natl Acad Sci USA 1994;91:609-613.
20. Huang C, Ma WY, Dawson MI, Rincon M, Flavell RA, Dong Z. Blocking activator protein-1 activity, but not activating retinoic acid response element, is required for the antitumor promotion effect of retinoic acid. Proc Natl Acad Sci USA 1997;94:5826-5830.
21. Li JJ, Dong Z, Dawson MI, Colburn NH. Inhibition of tumor promoter-induced transformation by retinoids that transrepress ap-1 without transactivating retinoic acid response element. Cancer Res 1996;56:483-489.
22. Huang C, Ma W-Y, Dong Z. Inhibitory effects of ascorbic acid on ap-1 activity and transformation of jb6 cells. Int J Oncol 1996;8:389-393.
23. Dong Z, Crawford HC, Lavrovsky V, et al. A dominant negative mutantof jun blocking 12-o-tetradecanoylphorbol-13- acetate-induced invasion in mouse keratinocytes. Mol Carcinog 1997;19:204-212.
24. Cowley S, Paterson H, Kemp P, Marshall CJ. Activation of map kinase kinase is necessary and sufficient for pc12 differentiation and for transformation of nih 3t3 cells. Cell 1994;77:841-852.
25. Huang C, Ma WY, Li J, Dong Z. Arsenic induces apoptosis through a c-jun nh2-terminal kinase- dependent, p53-independent pathway. Cancer Res 1999;59:3053-3058.
26. Hong WK. General keynote: The impact of cancer chemoprevention. Gynecol Oncol 2003;88:S56-58.
27. Trevisanato SI, Kim YI. Tea and health. Nutr Rev 2000;58:1-10.
28. Yang CS, Yang GY, Lee ML, Chen L. Mechanistic considerations of the inhibition of carcinogenesis by tea. In: Ohigashi H, editor. Proceedings of the International Conference on Food Factor in Cancer Prevention. Tokyo: Springer-Verlag, 1997, pp 113-117.
29. Yang CS, Wang ZY. Tea and cancer. J Natl Cancer Inst 1993; 85:1038-1049.
30. Katiyar SK, Mukhtar H. Tea in chemoprevention of cancer: Epidemiologic and experimental studies. Int J Oncology 1996;8:221-238.
31. Dreosti IE, Wargovich MJ, Yang CS. Inhibition of carcinogenesis by tea: The evidence from experimental studies. Crit Rev Food Sci Nutr 1997;37:761-770.
32. Yang CS, Chung JY, Yang G, Chhabra SK, Lee MJ. Tea and tea polyphenols in cancer prevention. J Nutr 2000;130:472S-478S.
33. Graham HN. Green tea composition, consumption, and polyphenol chemistry. Prev Med 1992;21:334-350.
34. Huang MT, Ho CT, Wang ZY, et al. Inhibitory effect of topical application of a green tea polyphenol fraction on tumor initiation and promotion in mouse skin. Carcinogenesis 1992;13:947-954.
35. Yang CS. Inhibition of carcinogenesis by tea. Nature 1997;389:134-135.
36. Jankun J, Selman SH, Swiercz R, Skrzypczak-Jankun E. Why drinking green tea could prevent cancer. Nature 1997;387:561.
37. Dong Z, Ma W, Huang C, Yang CS. Inhibition of tumor promoter-induced activator protein 1 activation and cell transformation by tea polyphenols, (-)-epigallocatechin gallate, and theaflavins. Cancer Res 1997;57:4414-4419.
38. Chen NY, Ma WY, Yang CS, Dong Z. Inhibition of arsenite-induced apoptosis and ap-1 activity by epigallocatechin-3-gallate and theaflavins. J Environ Pathol Toxicol Oncol 2000;19:287-295.
39. Ahn HY, Hadizadeh KR, Seul C, Yun YP, Vetter H, Sachinidis A. Epigallocathechin-3 gallate selectively inhibits the pdgfbb-induced intracellular signaling transaction pathway in vascular smooth muscle cells and inhibits transformation of sis-transfected nih 3t3 fibroblasts and human glioblastoma cells (a172). Mol Biol Cell 1999;10:1093-1104.
40. Dong Z, Cmarik JL, Wendel EJ, Colburn NH. Differential transformation efficiency but not ap-1 induction under anchorage-dependent and -independent conditions. Carcinogenesis 1994;15:1001-1004.
41. Dong Z, Cmarik JL. Harvesting cells under anchorage-independent cell transformation conditions for biochemical analyses. Sci STKE 2002;2002:PL7.
42. Colburn NH, Former BF, Nelson KA, Yuspa SH. Tumour promoter induces anchorage independence irreversibly. Nature 1979;281:589-591.
43. Colburn NH, Wendel EJ, Abruzzo G. Dissociation of mitogenesis and late-stage promotion of tumor cell phenotype by phorbol esters: Mitogen-resistant variants are sensitive to promotion. Proc Natl Acad Sci USA 1981;78:6912-6916.
44. Dong Z, Lavrovsky V, Colburn NH. Transformation reversion induced in jb6 rt101 cells by ap-1 inhibitors. Carcinogenesis 1995;16:749-756.
45. Lavrovsky V, Dong Z, Ma WY, Colburn N. Drug-induced reversion of progression phenotype is accompanied by reversion of ap-1 phenotype in jb6 cells. In Vitro Cell Dev Biol Anim 1996;32:234-237.
46. Chung JY, Huang C, Meng X, Dong Z, Yang CS. Inhibition of activator protein 1 activity and cell growth by purified green tea and black tea polyphenols in h-ras-transformed cells: Structure-activity relationship and mechanisms involved. Cancer Res 1999;59:4610-4617.
47. Barthelman M, Bair WB, III, Stickland KK, et al. (-)-epigallocatechin-3- gallate inhibition of ultraviolet b-induced ap-1 activity. Carcinogenesis 1998;19:2201-2204.
48. Nomura M, Ma WY, Huang C, et al. Inhibition of ultraviolet b-induced ap-1 activation by theaflavins from black tea. Mol Carcinog 2000;28:148-155.
49. Chen W, Dong Z, Valcic S, Timmermann BN, Bowden GT. Inhibition of ultraviolet b-induced c-fos gene expression and p38 mitogen-activated protein kinase activation by (-)-epigallocatechin gallate in a human keratinocyte cell line. Mol Carcinog 1999;24:79-84.
50. Gilmore TD. Clinically relevant findings (editorial). J Clin Invest 1997;100:2935-2936.
51. Afaq F, Adhami VM, Ahmad N, Mukhtar H. Inhibition of ultraviolet b-mediated activation of nuclear factor kappab in normal human epidermal keratinocytes by green tea constituent (-)-epigallocatechin-3-gallate. Oncogene 2003;22:1035-1044.
52. Nomura M, Ma W, Chen N, Bode AM, Dong Z. Inhibition of 12-o-tetradecanoylphorbol-13-acetate-induced NF-kappaB activation by tea polyphenols, (-)-epigallocatechin gallate and theaflavins. Carcinogenesis 2000;21:1885-1890.
53. Nam S, Smith DM, Dou QP. Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo. J Biol Chem 2001;276:13322-13330.
54. Ahmad N, Gupta S, Mukhtar H. Green tea polyphenol epigallocatechin-3- gallate differentially modulates nuclear factor kappab in cancer cells versus normal cells. Arch Biochem Biophys 2000;376:338-346.
55. Vivanco I, Sawyers CL. The phosphatidylinositol 3-kinase akt pathway in human cancer. Nat Rev Cancer 2002;2:489-501.
56. Nomura M, Kaji A, He Z, et al. Inhibitory mechanisms of tea polyphenols on the ultraviolet b-activated phosphatidylinositol 3-kinase-dependent pathway. J Biol Chem 2001;276:46624-46631.
57. Pianetti S, Guo S, Kavanagh KT, Sonenshein GE. Green tea polyphenol epigallocatechin-3 gallate inhibits her-2/neu signaling, proliferation, and transformed phenotype of breast cancer cells. Cancer Res 2002;62:652-655.
58. Lee SJ, Lee IS, Mar W. Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 activity by 1,2,3,4,6-penta-o-galloyl-beta-D-glucose in murine macrophage cells. Arch Pharm Res 2003;26:832-839.
59. Park JW, Choi YJ, Suh SI, Kwon TK. Involvement of erk and protein tyrosine phosphatase signaling pathways in EGCG-induced cyclooxygenase-2 expression in raw 264.7 cells. Biochem Biophys Res Commun 2001;286:721-725.
60. Li ZG, Shimada Y, Sato F, et al. Inhibitory effects of epigallocatechin-3-gallate on n-nitrosomethylbenzylamine-induced esophageal tumorigenesis in f344 rats. Int J Oncol 2002;21:1275-1283.
61. An KP, Athar M, Tang X, et al. Cyclooxygenase-2 expression in murine and human nonmelanoma skin cancers: Implications for therapeutic approaches. Photochem Photobiol 2002;76:73-80.
62. Kundu JK, Na HK, Chun KS, et al. Inhibition of phorbol ester-induced cox-2 expression by epigallocatechin gallate in mouse skin and cultured human mammary epithelial cells. J Nutr 2003;133:3805S-3810S.
63. Chen C, Shen G, Hebbar V, Hu R, Owuor ED, Kong AN. Epigallocatechin-3- gallate-induced stress signals in ht-29 human colon adenocarcinoma cells. Carcinogenesis 2003;24:1369-1378.
64. Hastak K, Gupta S, Ahmad N, Agarwal MK, Agarwal ML, Mukhtar H. Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of lncap cells. Oncogene 2003;22:4851-4859.
65. Kuo PL, Lin CC. Green tea constituent (-)-epigallocatechin-3-gallate inhibits hep g2 cell proliferation and induces apoptosis through p53-dependent and fas-mediated pathways. J Biomed Sci 2003;10:219-227.
66. Chung JH, Han JH, Hwang EJ, et al. Dual mechanisms of green tea extract (EGCG)-induced cell survival in human epidermal keratinocytes. FASEB J 2003;17:1913-1915.
67. Chung JY, Park JO, Phyu H, Dong Z, Yang CS. Mechanisms of inhibition of the ras-map kinase signaling pathway in 30.7b ras 12 cells by tea polyphenols (-)-epigallocatechin-3-gallate and theaflavin-3,3′-digallate. FASEB J 2001;15:2022-2024.
68. Pan MH, Lin-Shiau SY, Ho CT, Lin JH, Lin JK. Suppression of lipopolysaccharide-induced nuclear factor-kappab activity by theaflavin-3,3′-digallate from black tea and other polyphenols through down-regulation of ikappab kinase activity in macrophages. Biochem Pharmacol 2000;59:357-367.
69. Zykova TA, Zhang Y, Zhu F, Bode AM, Dong Z. The signal transduction networks required for phosphorylation of stat1 at ser727 in mouse epidermal jb6 cells in the UVB response and inhibitory mechanisms of tea polyphenols. Carcinogenesis 2005;26:331-342.
70. Mizuno H, Cho Y-Y, Zhu F, et al. Theaflavin-3, 3′-digallate induces epidermal growth factor receptor down-regulation. Mol Carcinog 2006;45:1-9.
71. He Z, Ma WY, Hashimoto T, Bode AM, Yang CS, Dong Z. Induction of apoptosis by caffeine is mediated by the p53, bax, and caspase 3 pathways. Cancer Res 2003;63:4396-4401.
72. Marzo I, Brenner C, Zamzami N, et al. Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science 1998;281:2027-2031.
73. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death. Cell 1993;74:609-619.
74. Hoshi T, Sasano H, Kato K, et al. Immunohistochemistry of caspase3/cpp32 in human stomach and its correlation with cell proliferation and apoptosis. Anticancer Res 1998;18:4347-4353.
75. Wang X. The expanding role of mitochondria in apoptosis. Genes Dev 2001;15:2922-2933.
76. Hashimoto T, He Z, Ma WY, et al. Caffeine inhibits cell proliferation by G0/G1 phase arrest in jb6 cells. Cancer Res 2004;64:3344-3349.
77. Stein GH, Dulic V. Origins of G1 arrest in senescent human fibroblasts. Bioessays 1995;17:537-543.
78. Kitagawa M, Higashi H, Jung HK, et al. The consensus motif for phosphorylation by cyclin d1-cdk4 is different from that for phosphorylation by cyclin a/e-cdk2. EMBO J 1996;15:7060-7069.
79. Kato J, Matsushime H, Hiebert SW, Ewen ME, Sherr CJ. Direct binding of cyclin d to the retinoblastoma gene product (prb) and prb phosphorylation by the cyclin d-dependent kinase cdk4. Genes Dev 1993;7:331-342.
80. Taya Y. Rb kinases and Rb-binding proteins: New points of view. Trends Biochem Sci 1997;22:14-17.
81. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell 1995;81:323-330.
82. Diehl JA, Cheng M, Roussel MF, Sherr CJ. Glycogen synthase kinase-3beta regulates cyclin d1 proteolysis and subcellular localization. Genes Dev 1998;12:3499-3511.
83. Foukas LC, Daniele N, Ktori C, Anderson KE, Jensen J, Shepherd PR. Direct effects of caffeine and theophylline on p110 delta and other phosphoinositide 3-kinases. Differential effects on lipid kinase and protein kinase activities. J Biol Chem 2002;277:37124-37130.
84. Sazuka M, Isemura M, Isemura S. Interaction between the carboxyl-terminal heparin-binding domain of fibronectin and (-)-epigallocatechin gallate. Biosci Biotechnol Biochem 1998;62:1031-1032.
85. Hayakawa S, Saeki K, Sazuka M, et al. Apoptosis induction by epigallocatechin gallate involves its binding to fas. Biochem Biophys Res Commun 2001;285:1102-1106.
86. Suzuki Y, Isemura M. Inhibitory effect of epigallocatechin gallate on adhesion of murine melanoma cells to laminin. Cancer Lett 2001;173:15-20.
87. Tachibana H, Koga K, Fujimura Y, Yamada K. A receptor for green tea polyphenol EGCG. Nat Struct Mol Biol 2004;11:380-381.
88. Ermakova S, Choi BY, Choi HS, Kang BS, Bode AM, Dong Z. The intermediate filament protein vimentin is a new target for epigallocatechin gallate. J Biol Chem 2005;280:16882-16890.
89. Chou YH, Goldman RD. Intermediate filaments on the move. J Cell Biol 2000;150:F101-106.
90. Yang CS, Maliakal P, Meng X. Inhibition of carcinogenesis by tea. Annu Rev Pharmacol Toxicol 2002;42:25-54.
91. Liang YC, Chen YC, Lin YL, Lin-Shiau SY, Ho CT, Lin JK. Suppression of extracellular signals and cell proliferation by the black tea polyphenol, theaflavin-3,3′-digallate. Carcinogenesis 1999;20:733-736.
92. Kavanagh KT, Hafer LJ, Kim DW, et al. Green tea extracts decrease carcinogen-induced mammary tumor burden in rats and rate of breast cancer cell proliferation in culture. J Cell Biochem 2001;82:387-398.
93. Islam S, Islam N, Kermode T, et al. Involvement of caspase-3 in epigallocatechin-3-gallate-mediated apoptosis of human chondrosarcoma cells. Biochem Biophys Res Commun 2000;270:793-797.
94. Brusselmans K, De Schrijver E, Heyns W, Verhoeven G, Swinnen JV. Epigallocatechin-3-gallate is a potent natural inhibitor of fatty acid synthase in intact cells and selectively induces apoptosis in prostate cancer cells. Int J Cancer 2003;106:856-862.